|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01530 3SBIO
Nominal 
13.060 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 9,107,978 | 16.531% | 7,815,938 | 6,865,735 | 6,382,009 | 5,587,636 |
| Cost of Sales | (1,279,602) | 8.967% | (1,174,298) | (1,194,161) | (1,106,286) | (1,062,911) |
| Gross Profit | 7,828,376 | 17.868% | 6,641,640 | 5,671,574 | 5,275,723 | 4,524,725 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 348,932 | -- | (29,795) | (34,247) | (37,101) | (30,393) | |
| Profit / (Loss) before Taxation | 2,718,085 | 37.384% | 1,978,459 | 2,279,596 | 1,868,766 | 979,129 | |
| Taxation | (500,536) | 27.633% | (392,167) | (370,737) | (241,193) | (208,023) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (127,229) | 243.370% | (37,053) | 6,868 | 23,674 | 64,685 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,090,320 | 34.926% | 1,549,239 | 1,915,727 | 1,651,247 | 835,791 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 43,065 | -27.221% | 59,172 | (46,739) | (7,923) | (3,436) |
| Depreciation & Amortisation | 412,622 | 17.402% | 351,462 | 398,157 | 338,324 | 367,318 |
| Directors' Emoluments | -- | -- | 8,137 | 7,356 | 7,307 | 7,065 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 86.000 | 34.375% | 64.000 | 78.000 | 65.000 | 33.000 |
| DPS (cts) | 23.072 | -- | 22.678 | 8.757 | 16.258 | 0.000 |
| Dividend Payout Ratio (%) | 26.827% | -- | 35.434% | 11.226% | 25.012% | -- |
| Cash flow per share ($) | -- | -- | 0.854 | 0.873 | 0.621 | 0.530 |
| NBV per share ($) | 6.444 | -- | 5.754 | 5.300 | 4.848 | 4.202 |
| Remarks: | Real time quote last updated: 02/04/2025 07:57 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,090,320 |
| %Change | 34.926% |
| EPS / (LPS) | RMB 0.860 |
| NBV Per Share (¥) | RMB 6.444 |